about
Signaling of miRNAs-FOXM1 in cancer and potential targeted therapyFOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathwaysTargeting miRNAs for pancreatic cancer therapyMiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsInference of transcriptional regulation in cancers.Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors.A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESSST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.Novel functions of FoxM1: from molecular mechanisms to cancer therapyFOXM1 is a therapeutic target for high-risk multiple myeloma.Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.Association of FOXM1 expression with tumor histology and prognosis in Wilms tumor: Potential for a new prognostic marker.Expression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancerMiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.The roles of FOXM1 in pancreatic stem cells and carcinogenesisPeroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesisThe role of transcription factors in prostate cancer and potential for future RNA interference therapy.Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors.Bioethical conflicts of gene therapy: a brief critical review.EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX.YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function.Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1.FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors.Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancyExpression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.Is there potential to target FOXM1 for 'undruggable' lung cancers?Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.Mutual Regulation of FOXM1, NPM and ARF Proteins.Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance.FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesDual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers.TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancerRegulation of UNC-130/FOXD-mediated mesodermal patterning in C. elegans.Voriconazole exposure regulates distinct cell-cycle and terminal differentiation pathways in primary human keratinocytes.Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation.
P2860
Q26825764-4834209D-3B7B-4A1D-9571-CB35BFF57C1CQ28076296-A161EE64-C66D-43E2-B0D0-39FEB3EA3F56Q33962488-E8335780-44AF-411F-8522-9A63E156E59EQ34089034-9F2287E2-AD19-495B-8942-5A487ADBF76CQ34956879-BCA231D2-24D7-47A2-876E-8EC28D96FEACQ35795938-AD15CAAE-83D2-4948-A2C7-017AC51595CDQ35859678-0449E179-FCD9-45BF-83FA-B29BD0EB4F2FQ36419222-0B8A1275-ED5E-4506-A013-D202D988D04CQ36585186-692DB32F-2261-4B75-8C62-6283724734F2Q36657633-F891CF91-53C8-419A-8BFB-B36620FE7AFDQ36783627-AE19325D-0D3B-474B-99AA-3948E2BDC262Q36882572-AEDB43FC-8F89-47BB-9BB4-9037DFB72541Q37288367-E1DB0FF3-1EDF-45DE-B3F7-8ADD6FA6DECBQ37288489-4C67F352-03F8-4583-BD50-6439EAA951F7Q37301794-CB2FDFFD-8823-4666-BB99-5BE910E3FE19Q37583296-17B93B6C-A455-470D-B4FA-5A2461BDF1D4Q37708749-BDCE7A81-7288-4A50-B215-F7842B95DB12Q38198726-24BA568E-A265-4C1C-A28E-C83E31C3A6C0Q38237068-C4D6AF1F-2FAF-4FF1-BB3C-A10E7A0D832FQ38343860-AD36D328-771E-4021-B0BC-56135009A27CQ38563638-E83314FB-A38C-41EC-A25F-BA4D4EEA68D8Q38645501-262688B6-8E96-4979-ADA6-2C2E973F50B4Q38737771-804E90B3-C656-481E-A3F7-0D49ECA74C62Q38751212-D8D0F471-86DC-41AE-85A8-9709CFC37F7CQ38815782-268DF32A-E9B6-4AE2-99F2-CB892EE9A475Q38833602-85B47228-69CF-49A8-B442-378954A8A5E5Q38896592-648B9806-985D-417E-8D47-BE780D8EA32BQ38995507-9FD0984A-3AAA-4120-A9FC-479273352C93Q39930415-6B55E5B5-225C-4491-935F-2673CC86EEE7Q40332020-AA34BEB2-87AA-4EF1-A219-02DD6DEE11CCQ40622697-11991513-2EB3-4900-BFF4-00D26CE0ADA7Q40922584-6A175232-71D7-4F74-AB2A-F4E65A43036BQ41195919-2020BEDA-7D76-48E4-97A9-CCE49EE3F644Q41471202-60556E79-5AEB-4116-B0BA-FE28AD293A65Q41660592-407C682B-6882-4AAC-988A-9301C72795C3Q41874296-10566065-E03A-402E-AF1E-A28AD70AACF1Q42292977-A2A01342-E708-4EE6-B207-5F7FA06518B9Q42359773-9968DB93-C739-4642-AC4B-EB774A38A4ABQ44997320-0ACE13B0-94BE-483B-8400-02C426A25C0AQ46256338-E2CE3BBB-2850-40A4-96F7-FB69C80A21B0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting FOXM1 in cancer.
@en
type
label
Targeting FOXM1 in cancer.
@en
prefLabel
Targeting FOXM1 in cancer.
@en
P1476
Targeting FOXM1 in cancer.
@en
P2093
Andrei L Gartel
Marianna Halasi
P304
P356
10.1016/J.BCP.2012.10.013
P407
P577
2012-10-24T00:00:00Z